Journal of Internal Medicine Concepts & Practice ›› 2023, Vol. 18 ›› Issue (06): 424-430.doi: 10.16138/j.1673-6087.2023.06.009
• Research report • Previous Articles Next Articles
YANG Siheng1a, ZHANG Xuewu1a, HU Guoqi1a, ZHANG Yan1a, LI Ziqiang1b, SHENG Zike2a, XU Yumin2b()
Received:
2023-05-18
Online:
2023-12-18
Published:
2024-03-18
CLC Number:
YANG Siheng, ZHANG Xuewu, HU Guoqi, ZHANG Yan, LI Ziqiang, SHENG Zike, XU Yumin. Analysis of distribution and drug resistance of pathogenic bacteria of bloodstream infection in a tertiary hospital from 2019 to 2022[J]. Journal of Internal Medicine Concepts & Practice, 2023, 18(06): 424-430.
病原菌 | 2019—2020年 | 2021—2022年 | 合计 | |||||
---|---|---|---|---|---|---|---|---|
株数(n=226) | 构成比(%) | 株数(n=442) | 构成比(%) | 株数(n=668) | 构成比(%) | |||
革兰阴性菌 | 164 | 72.57 | 297 | 67.19 | 461 | 69.01 | ||
大肠埃希菌 | 106 | 46.90 | 168 | 38.01 | 274 | 41.01 | ||
肺炎克雷伯菌 | 24 | 10.62 | 67 | 15.16 | 91 | 13.62 | ||
铜绿假单胞菌 | 10 | 4.42 | 13 | 2.94 | 23 | 3.44 | ||
鲍曼不动杆菌 | 5 | 2.21 | 11 | 2.49 | 16 | 2.40 | ||
嗜麦芽窄食单胞菌 | 6 | 2.65 | 5 | 1.13 | 11 | 1.65 | ||
洋葱伯克霍尔德菌 | 3 | 1.32 | 7 | 1.58 | 10 | 1.50 | ||
其他革兰阴性菌 | 10 | 4.42 | 26 | 5.88 | 36 | 5.39 | ||
革兰阳性菌 | 62 | 27.43 | 143 | 32.35 | 205 | 30.69 | ||
金黄色葡萄球菌 | 13 | 5.75 | 21 | 4.75 | 34 | 5.09 | ||
凝固酶阴性葡萄球菌 | 48 | 21.24 | 93 | 21.04 | 141 | 21.10 | ||
屎肠球菌 | 1 | 0.44 | 11 | 2.49 | 12 | 1.80 | ||
粪肠球菌 | 0 | 0 | 5 | 1.13 | 5 | 0.75 | ||
其他革兰阳性菌 | 0 | 0 | 13 | 2.94 | 13 | 1.95 | ||
真菌 | 0 | 0 | 2 | 0.46 | 2 | 0.30 | ||
白色念珠菌 | 0 | 0 | 1 | 0.23 | 1 | 0.15 | ||
光滑念珠菌 | 0 | 0 | 1 | 0.23 | 1 | 0.15 |
抗菌药物 | 大肠埃希菌(n=274) | 肺炎克雷伯菌(n=91) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
2019—2020年 | 2021—2022年 | χ2 | P | 合计 | 2019—2020年 | 2021—2022年 | χ2 | P | 合计 | ||
阿米卡星 | 0.94 | 4.76 | 2.983 | 0.084 | 3.28 | 12.50 | 7.46 | 0.559 | 0.455 | 8.79 | |
氨苄西林 | 88.68 | 88.02 | 0.027 | 0.870 | 88.32 | 100.00 | 89.55 | 2.716 | 0.099 | 92.31 | |
氨苄西林/舒巴坦 | 60.38 | 51.19 | 1.725 | 0.189 | 54.74 | 25.00 | 22.39 | 0.068 | 0.794 | 23.08 | |
氨曲南 | 41.90 | 36.76 | 0.658 | 0.417 | 39.00 | 16.67 | 17.86 | 0.016 | 0.899 | 17.40 | |
亚胺培南 | 0.94 | 1.79 | 0.321 | 0.571 | 1.46 | 12.50 | 5.97 | 1.061 | 0.303 | 6.59 | |
厄他培南 | 0.94 | 1.79 | 0.321 | 0.571 | 1.46 | 12.50 | 5.97 | 1.061 | 0.303 | 6.59 | |
呋喃妥因 | 96.19 | 84.33 | 7.919 | 0.004 | 90.96 | 100.00 | 81.82 | 4.877 | 0.027 | 89.47 | |
复方磺胺甲噁唑 | 52.83 | 60.12 | 1.411 | 0.235 | 57.30 | 8.33 | 29.85 | 4.463 | 0.035 | 24.18 | |
环丙沙星 | 60.00 | 62.77 | 0.193 | 0.660 | 56.20 | 20.83 | 30.36 | 0.764 | 0.382 | 27.50 | |
哌拉西林/他唑巴坦 | 3.75 | 8.33 | 2.202 | 0.138 | 6.57 | 12.50 | 10.45 | 0.076 | 0.783 | 10.99 | |
庆大霉素 | 44.76 | 31.85 | 4.200 | 0.040 | 37.50 | 12.50 | 30.91 | 2.995 | 0.084 | 22.37 | |
替加环素 | 0 | 0 | - | - | 0 | 0 | 0 | - | - | 0 | |
头孢吡肟 | 27.36 | 37.35 | 2.900 | 0.089 | 33.46 | 16.67 | 17.91 | 0.019 | 0.891 | 17.58 | |
头孢曲松 | 67.92 | 57.14 | 3.185 | 0.074 | 61.31 | 20.83 | 31.34 | 0.956 | 0.328 | 28.57 | |
头孢他啶 | 30.19 | 27.97 | 0.155 | 0.694 | 22.38 | 12.50 | 16.42 | 0.208 | 0.648 | 15.38 | |
头孢替坦 | 3.77 | 7.78 | 1.786 | 0.181 | 3.23 | 12.50 | 13.43 | 0.013 | 0.908 | 13.19 | |
妥布霉素 | 15.64 | 17.89 | 0.286 | 0.593 | 16.67 | 12.50 | 8.16 | 0.350 | 0.554 | 9.59 | |
左氧氟沙星 | 51.89 | 52.69 | 0.017 | 0.896 | 52.38 | 16.67 | 31.34 | 1.910 | 0.166 7 | 27.47 |
抗菌药物 | 铜绿假单胞菌(n=23) | 鲍曼不动杆菌(n=16) | 嗜麦芽窄食单胞菌(n=11) | 洋葱伯克霍尔德菌(n=10) |
---|---|---|---|---|
阿米卡星 | 0 | - | - | 100.00 |
氨苄西林/舒巴坦 | - | 68.79 | - | |
氨曲南 | - | - | 100.00 | |
亚胺培南 | 17.39 | 50.00 | - | 60.00 |
复方磺胺甲噁唑 | 31.25 | 0 | 0 | |
环丙沙星 | 30.43 | 68.75 | - | 100.00 |
哌拉西林/他唑巴坦 | 21.74 | 42.85 | - | 50.00 |
庆大霉素 | 5.26 | 62.50 | - | 60.00 |
头孢吡肟 | 17.39 | 50.00 | - | 50.00 |
头孢曲松 | - | 62.50 | - | - |
头孢他啶 | 17.39 | 62.50 | 71.43 | 10.00 |
妥布霉素 | 4.35 | 56.25 | - | 70.00 |
左氧氟沙星 | 30.43 | 50.00 | 22.22 | 80.00 |
抗菌药物 | 金黄色葡萄球菌(n=34) | 凝固酶阴性葡萄球菌(n=141) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
2019—2020年 | 2021—2022年 | χ2 | P | 合计 | 2019—2020年 | 2021—2022年 | χ2 | P | 合计 | ||
苯唑西林 MIC | 76.92 | 76.19 | 0.002 | 0.961 | 76.47 | 87.50 | 82.79 | 0.532 | 0.466 | 84.39 | |
头孢西丁筛选阳性 | 76.92 | 76.19 | 0.002 | 0.961 | 76.47 | 85.42 | 81.72 | 0.306 | 0.580 | 82.98 | |
复方磺胺甲噁唑 | 38.46 | 19.05 | 1.555 | 0.212 | 26.47 | 43.75 | 52.69 | 1.012 | 0.315 | 49.65 | |
红霉素 | 76.92 | 61.90 | 0.828 | 0.363 | 67.65 | 85.42 | 84.95 | 0.006 | 0.941 | 85.11 | |
环丙沙星 | 30.77 | 14.29 | 1.334 | 0.248 | 20.59 | 41.67 | 47.31 | 0.407 | 0.524 | 45.39 | |
克林霉素 | 76.92 | 47.62 | 2.847 | 0.092 | 58.82 | 68.75 | 52.69 | 3.356 | 0.067 | 58.16 | |
奎奴普丁/达福普汀 | 0 | 0 | - | - | 0 | 0 | 0 | - | - | 0 | |
利福平 | 0 | 4.76 | 0.638 | 0.425 | 2.94 | 0 | 4.30 | 2.125 | 0.145 | 2.84 | |
利奈唑胺 | 0 | 0 | - | - | 0 | 0 | 0 | - | - | 0 | |
莫西沙星 | 15.38 | 14.29 | 0.008 | 0.930 | 14.71 | 18.75 | 36.56 | 4.737 | 0.029 | 30.50 | |
青霉素 | 100 | 100 | - | - | 100 | 91.67 | 91.40 | 0.003 | 0.957 | 91.49 | |
庆大霉素 | 30.77 | 9.82 | 2.494 | 0.114 | 17.65 | 18.75 | 15.05 | 0.317 | 0.573 | 16.31 | |
四环素 | 15.38 | 0 | 3.433 | 0.064 | 5.88 | 33.33 | 33.33 | - | - | 33.33 | |
替加环素 | 0 | 0 | - | - | 0 | 0 | 0 | - | - | 0 | |
万古霉素 | 0 | 0 | - | - | 0 | 0 | 0 | - | - | 0 | |
左氧氟沙星 | 23.08 | 19.05 | 0.080 | 0.778 | 20.59 | 33.33 | 46.24 | 2.166 | 0.141 | 41.84 |
[1] | 杨祖耀, 詹思延, 王波, 等. 中国血流感染住院病死率的系统评价和meta分析[J]. 北京大学学报(医学版), 2010, 42(3): 304-307. |
[2] |
Rhee C, Dantes R, Epstein L, et al. Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009-2014[J]. JAMA, 2017, 318(13):1241-1249.
doi: 10.1001/jama.2017.13836 URL |
[3] |
Isendahl J, Giske CG, Tegmark Wisell K, et al. Risk factors for community-onset bloodstream infection with extended-spectrum β-lactamase-producing Enterobacteriaceae: national population-based case-control study[J]. Clin Microbiol Infect, 2019, 25(11): 1408-1414.
doi: 10.1016/j.cmi.2019.04.002 URL |
[4] | 中国医师协会急诊医师分会, 中国研究型医院学会休克与脓毒症专业委员会. 中国脓毒症/脓毒性休克急诊治疗指南(2018)[J]. 感染、炎症、修复, 2019, 20(1): 3-22. |
[5] | 刘周, 徐晨, 姚杰, 等. 血流感染肠杆菌科细菌临床分布与耐药性研究[J]. 中华医院感染学杂志, 2015, 25(24): 5559-5561. |
[6] | 胡田雨, 陈雪娥, 金浩龙, 等. 某三甲综合医院医院获得性血流感染病原菌分布及耐药性分析[J]. 中华医院感染学杂志, 2018, 28(8): 1139-1143. |
[7] |
Quan J, Li X, Chen Y, et al. Prevalence of MCR-1 in Escherichia coli and Klebsiella pneumoniae recovered from bloodstream infections in China: a multicentre longitudinal study[J]. Lancet Infect Dis, 2017, 17(4): 400-410.
doi: 10.1016/S1473-3099(16)30528-X URL |
[8] | 全国细菌耐药监测网. 2014-2019年血标本病原菌耐药性变迁[J]. 中国感染控制杂志, 2021, 20(2): 124-133. |
[9] | 邵盼盼, 许磊, 高有方. 2014-2018年某医院血培养阳性病原菌分布及耐药性分析[J]. 安徽医药, 2020, 24(6): 1202-1205. |
[10] |
Chong Y, Shimoda S, Shimono N. Current epidemiology, genetic evolution and clinical impact of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae[J]. Infect Genet Evol, 2018, 61: 185-188.
doi: S1567-1348(18)30178-3 pmid: 29626676 |
[11] |
Dikoumba AC, Onanga R, Boundenga L, et al. Prevalence and characterization of extended-spectrum beta-lactamase-producing enterobacteriaceae in major hospitals in Gabon[J]. Microb Drug Resist, 2021, 27(11): 1525-1534.
doi: 10.1089/mdr.2020.0497 URL |
[12] | 李耘, 郑波, 吕媛, 等. 中国细菌耐药监测(CARST)研究2019-2020革兰氏阴性菌监测报告[J]. 中国临床药理学杂志, 2022, 38(5): 432-452. |
[13] | 王群, 王亦晨, 张祎博, 等. 2016-2020年某三级综合医院耐碳青霉烯类肺炎克雷伯菌检出趋势[J]. 中华医院感染学杂志, 2022, 32(6): 835-839. |
[14] | 卞秀娟, 包志瑶, 陈虹, 等. 血流感染耐碳青霉烯类肺炎克雷伯菌患者的死亡危险因素分析[J]. 内科理论与实践, 2022, 17(1): 73-77. |
[15] |
Gudiol C, Cuervo G, Carratalà J. Optimizing therapy of bloodstream infection due to extended-spectrum β-lactamase-producing Enterobacteriaceae[J]. Curr Opin Crit Care, 2019, 25(5): 438-448.
doi: 10.1097/MCC.0000000000000646 URL |
[16] |
Xiao Y, Hang Y, Chen Y, et al. A retrospective analysis of risk factors and patient outcomes of bloodstream infection with extended-spectrum β-lactamase-producing Escherichia coli in a Chinese tertiary hospital[J]. Infect Drug Resist, 2020, 13: 4289-4296.
doi: 10.2147/IDR.S269989 URL |
[17] | 全国细菌耐药监测网. 2020年全国细菌耐药监测报告[J]. 中华检验医学杂志, 2022, 45(2): 122-136. |
[18] | 何礼贤, 肖永红, 路权, 等. 国家抗微生物治疗指南[M]. 2版. 北京: 人民卫生出版社, 2018: 7-8. |
[19] |
Candel FJ, Matesanz David M, Barberán J. New perspectives for reassessing fosfomycin: applicability in current clinical practice[J]. Rev Esp Quimioter, 2019, 32 Suppl 1: 1-7.
pmid: 31131586 |
[20] | 伍婷婷, 曾吉, 景小鹏, 等. 血培养分离凝固酶阴性葡萄球菌的临床意义[J]. 中华传染病杂志, 2018, 36(11): 661-664. |
[21] | Elzi L, Babouee B, Vögeli N, et al. How to discriminate contamination from bloodstream infection due to coagulase-negative Staphylococci[J]. Clin Microbiol Infect, 2012, 18(9): E355-E361. |
[22] | 马序竹, 吕媛, 郑波. 卫生部全国细菌耐药监测网2011年血流感染细菌耐药监测[J]. 中国临床药理学杂志, 2012, 28(12): 927-932. |
[23] | 陈云波, 嵇金如, 刘志盈, 等. 全国血流感染细菌耐药监测(BRICS)2021年度报告[J]. 中华临床感染病杂志, 2023, 16(1): 33-47. |
[24] |
Walters MS, Eggers P, Albrecht V, et al. Vancomycin-resistant Staphylococcus aureus-Delaware, 2015[J]. MMWR Morb Mortal Wkly Rep, 2015, 64(37): 1056.
doi: 10.15585/mmwr.mm6437a6 URL |
[25] |
Shariati A, Dadashi M, Chegini Z, et al. The global prevalence of daptomycin, tigecycline, quinupristin/dalfopristin, and linezolid-resistant Staphylococcus aureus and coagulase-negative Staphylococci strains[J]. Antimicrob Resist Infect Control, 2020, 9(1): 56.
doi: 10.1186/s13756-020-00714-9 |
[26] |
Joshi S, Shallal A, Zervos M. Vancomycin-resistant enterococci: epidemiology, infection prevention, and control[J]. Infect Dis Clin North Am, 2021, 35(4): 953-968.
doi: 10.1016/j.idc.2021.07.002 URL |
[27] |
Zou J, Xia Y. Molecular characteristics and risk factors associated with linezolid-resistant Enterococcus faecalis infection in Southwest China[J]. J Glob Antimicrob Resist, 2020, 22:504-510.
doi: 10.1016/j.jgar.2020.03.027 URL |
[1] | BIAN Xiujuan, BAO Zhiyao, CHEN Hong, CHENG Luxiao, SHI Baoping. Analysis of risk factors for mortality in patients with bloodstream infection of Carbapenem-resistant Klebsiella pneumonia [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(01): 73-77. |
[2] | WANG Xuejie, CHEN Zijin, DU Wen, GU Feifei, YU Haijin, ZHANG Wen, CHEN Xiaonong. Risk factors of acute kidney injury in the patients with bloodstream infection caused by different pathogens [J]. Journal of Internal Medicine Concepts & Practice, 2021, 16(01): 22-26. |
[3] | . [J]. Journal of Internal Medicine Concepts & Practice, 2019, 14(06): 366-370. |
[4] | . [J]. Journal of Internal Medicine Concepts & Practice, 2016, 11(05): 301-304. |
[5] | . [J]. Journal of Internal Medicine Concepts & Practice, 2015, 10(05): 371-376. |
[6] | . [J]. Journal of Internal Medicine Concepts & Practice, 2013, 8(04): 234-240. |
[7] | . [J]. Journal of Internal Medicine Concepts & Practice, 2007, 2(01): 45-48. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||